Trade Summary

3 days ago, Allan Jonathan, serving as GENERAL COUNSEL & CORP SEC at Stoke Therapeutics, Inc. (STOK), sold 1,457 shares at $29.95 per share, for a total transaction value of $43,637.15. Following this transaction, Allan Jonathan now holds 18,086 shares of STOK.

This sale represents a 7.46% decrease in Allan Jonathan's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 16, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 18, 2026 at 4:18 PM ET, 2 days after the trade was made.

Stoke Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.